Position in ABPO
as of Dec 31, 2025
· filed Feb 17, 2026
Position Value
$0
+$0 QoQ
Shares Held
997,048
0.0% QoQ
Ownership
16.9%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABPO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Saba Capital Management, L.P. holds $534,576 across 8 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RNA |
Atrium Therapeutics, Inc.
|
39,640 | $533,158 | |
| 2 | OABI |
OmniAb, Inc.
|
18,000 | $1,418 | |
| 3 | OSRH |
OSR Health, Inc.
|
250,000 | $0 | |
| 4 | ASBP |
Aspire Biopharma Holdings, Inc.
|
983,603 | $0 | |
| 5 | PBM |
Psyence Biomedical Ltd.
|
297,847 | $0 | |
| 6 | CDIO |
Cardio Diagnostics Holdings, Inc.
|
199,839 | $0 | |
| 7 | LIMN |
Liminatus Pharma, Inc.
|
233,761 | $0 | |
| 8 | CDT |
CDT Equity Inc.
|
765,000 | $0 |
All Filings in ABPO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 ABPWW | — | 997,048 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 ABPWW | — | 997,048 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 ABPWW | — | 997,048 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 ABPWW | — | 997,048 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 ABPWW | — | 997,048 | Shares | Sole | 2025-02-14 | |
| 2023-03-31 ACAB | — | 1,772,500 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 ACAB | — | 1,772,500 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 ACAB | — | 1,772,500 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 ACAB | — | 1,720,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 ACAB | — | 1,300,000 | Shares | Sole | 2022-06-03 | |
| No filing history on record for this holder in this stock. | ||||||